AVANIR PHARMACEUTICALS INC's ticker is AVNR and the CUSIP is 05348P401. A total of 114 filers reported holding AVANIR PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $152,380,000 | +127.5% | 8,989,968 | +60.0% | 0.01% | +120.0% |
| Q3 2014 | $66,987,000 | +159.2% | 5,619,763 | +22.6% | 0.01% | +150.0% |
| Q2 2014 | $25,846,000 | +50.8% | 4,582,561 | -1.8% | 0.00% | +100.0% |
| Q1 2014 | $17,134,000 | +17.4% | 4,668,629 | +7.5% | 0.00% | 0.0% |
| Q4 2013 | $14,596,000 | -18.2% | 4,343,830 | +3.2% | 0.00% | -50.0% |
| Q3 2013 | $17,849,000 | -5.7% | 4,209,657 | +2.3% | 0.00% | 0.0% |
| Q2 2013 | $18,931,000 | – | 4,115,372 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,436,053 | $10,329,000 | 1.78% |
| GREAT POINT PARTNERS LLC | 200,000 | $846,000 | 0.59% |
| Tekla Capital Management LLC | 960,000 | $4,070,000 | 0.45% |
| Artal Group S.A. | 3,100,000 | $13,113,000 | 0.43% |
| Baker Brothers Advisors | 4,428,591 | $18,733,000 | 0.27% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,446,839 | $6,120,000 | 0.24% |
| FORTALEZA ASSET MANAGEMENT INC/ | 96,545 | $408,000 | 0.21% |
| EAM Investors, LLC | 236,609 | $1,003,000 | 0.20% |
| ASCEND CAPITAL, LLC | 979,370 | $4,143,000 | 0.15% |
| Orbimed Advisors | 1,863,400 | $7,882,000 | 0.14% |